- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abeona Therapeutics Inc (ABEO)
Track today's live Abeona Therapeutics (ABEO) share price, performance and key data on this page with our current NASDAQ:ABEO stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Abeona Therapeutics share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ABEO share price, head to our technical summary section, which provides analysis on Abeona Therapeutics share price buy/sell indicators using real-time data (or discuss the Abeona Therapeutics (ABEO) stock price today with other investors in the Abeona Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ABEO share price (ISIN: US00289Y2063) to enhance your trading decisions with our free investment tools and resources.
What Is the Abeona Therapeutics Inc Share Price Today?
The Abeona Therapeutics share price today is 5.9850.
What Is the Stock Symbol for Abeona Therapeutics Inc
The stock symbol (or 'ticker') for Abeona Therapeutics Inc is "ABEO."
What Stock Exchange Does Abeona Therapeutics Inc Trade On?
Abeona Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Abeona Therapeutics Inc a Good Stock to Buy?
Determining whether Abeona Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ABEO share price (ISIN: US00289Y2063) to enhance your trading decisions with our free investment tools and resources.
What Is the Abeona Therapeutics Inc Share Price Today?
The Abeona Therapeutics share price today is 5.9850.
What Is the Stock Symbol for Abeona Therapeutics Inc
The stock symbol (or 'ticker') for Abeona Therapeutics Inc is "ABEO."
What Stock Exchange Does Abeona Therapeutics Inc Trade On?
Abeona Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Abeona Therapeutics Inc a Good Stock to Buy?
Determining whether Abeona Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.8200
6.2900
52 wk Range
4.0000
7.6500
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.82006.2900
52 wk Range
4.00007.6500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABEO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
18.8571
Upside
+215.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.8571
(+215.07% Upside)
Abeona Therapeutics Inc Earnings Call Summary for Q2/2026
- ZEVASKYN Q2 revenue reached $11.4M, up 31% sequentially but missed $12.24M estimate; shares dropped 10.99% to $6.64 in premarket trading.
- Net loss widened to $20.2M ($0.35/share) from Q1's $17.1M as company scaled commercial operations and treatment center network to 7 sites.
- Manufacturing issues prevented revenue recognition for 2 of 5 treated patients; gross margin at 63% vs. long-term target of 85-90% at full capacity.
- CMS granted ZEVASKYN New Technology Add-on Payment status for fiscal 2027, expected to improve hospital reimbursement for Medicare patients.
- Company ended quarter with $146.8M cash; no formal guidance issued but management targets steady treatment cadence with 40% patient population access.
Last Updated: 13/08/2026, 14:42
Read Full TranscriptEarnings
Latest Release
13/08/2026
EPS / Forecast
-0.35 / -0.22
Revenue / Forecast
11.38M / 12.24M
Compare ABEO to Peers and Sector
Metrics to compare | ABEO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABEOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.4x | 5.6x | −0.4x | |
PEG Ratio | 0.02 | −0.21 | 0.00 | |
Price/Book | 2.7x | 2.7x | 2.6x | |
Price / LTM Sales | 13.4x | 8.6x | 3.1x | |
Upside (Analyst Target) | 184.0% | 154.8% | 48.3% | |
Fair Value Upside | Unlock | 15.3% | 6.2% | Unlock |
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Abeona Therapeutics (NASDAQ: ABEO) Share Price Today?
The Abeona Therapeutics stock price today is 5.9850 USD.
What Stock Exchange Does Abeona Therapeutics (ABEO) Trade On?
Abeona Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Abeona Therapeutics?
The stock symbol (also called a 'ticker') for Abeona Therapeutics is "ABEO."
What Is the Current Abeona Therapeutics Market Capitalisation?
As of today, Abeona Therapeutics (NASDAQ: ABEO) market cap is 342.2500M USD.
What Is Abeona Therapeutics's (ABEO) Earnings Per Share (TTM)?
The Abeona Therapeutics EPS is currently -1.1840 (Trailing Twelve Months).
When Is the Next Abeona Therapeutics Earnings Date?
Abeona Therapeutics's next earnings report will be released on 16/11/2026.
Is ABEO a Buy or Sell From a Technical Analyst Perspective?
Based on today's Abeona Therapeutics moving averages and other technical indicators, the daily buy/sell signal for ABEO stock is Strong Sell.
How Many Times Has Abeona Therapeutics Stock Split?
Abeona Therapeutics has split 4 times. (See the ABEO stock split history page for full effective split date and price information.)
How Many Employees Does Abeona Therapeutics Have?
Abeona Therapeutics has 226 employees, based on their latest Companies House report.
What is the current trading status of Abeona Therapeutics (NASDAQ: ABEO)?
As of 16/08/2026, Abeona Therapeutics (ABEO) is trading at a share price of 5.9850 USD, with a previous close of 6.3450 USD. The stock has fluctuated within a day range of 5.8200 USD to 6.2900 USD, while its 52-week range spans from 4.0000 USD to 7.6500 USD.
What Is Abeona Therapeutics (ABEO) Price Target According to Analysts?
The average 12-month price target for Abeona Therapeutics is 18.8571 USD, with a high estimate of 28 USD and a low estimate of 14 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +215.07% Upside potential.
What Is the ABEO Premarket Price?
ABEO's last pre-market stock price is 6.3700 USD. The pre-market share volume is 19,660.0000, and the stock has decreased by 0.0250, or 0.3900%.
What Is the ABEO After Hours Price?
ABEO's last after hours stock price is 6.0577 USD, the stock has decreased by 0.0727, or 1.2100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.